Cite

HARVARD Citation

    Perry, M. et al. (n.d.). AB1185 BUDGET IMPACT ANALYSIS OF INTRODUCING SUBCUTANEOUS INFLIXIMAB CT-P13 SC FROM THE UK PAYER PERSPECTIVE. Annals of the rheumatic diseases. p. 1883. [Online]. 
  
Back to record